1[1]Waagstein F.Hjalmarson A,Varnauskas E,et al. Effects of chronic beta-a drenergic receptor blockadt in congestive cardiomyopathy[J]. Br Heart J,1975,37: 1022-1036.
2[2]Gauthier C, Tavernier G,Charpentier F,et al. Functional β3-adrnoceptor in the human heart. J Clin lnvest[J],1996,98:556-552.
3[3]Thomas JA,Marks BH. Plasma nerepinephrme in congestive heart failure[J]. Am J Cardiol, 1978,41:233-243.
4[4]Cob JN,Levine. TB.Ohvari MT,et al. Plasma norepinephrine as a guide to pregosis in patients with chronic congestive heart failure[J]. N Eng J Med,1984,311,819-823.
5[5]Esler MD.Thompson JM,Kaye DM,et al. Effects of aging on the responsivencss of the human cardiac sympathetic nerves to stressors[J]. Circulation, l995,91 :351-358.
6[6]Kaye DM.Cox H,Lambert G,et al. Regional epinephrine kineties in severe beart fatlure :evidence for extra-adrenal nonncural release[J]. Am J Physiol,1995,269:H182-H188.
7[7]Esler M. Clinical application of noradrcnaline spillover methodology:delin cation of regional human sympathetic nervous responses [J ]. Pharmacol Toxicol, 1993.73: 243-253.
8[8]Mann DL,Kent RL,Parsons B.et al. Adrenergic effects on the biology of the adult mammalian cardiocyte[J ]. Circulation, 1992,85: 790-804.
9[9]Bristow MR. Changes in myocardial and vascular receptors in heart failure[J]. J Am Coll Cardiol,1993,22(suppl A):61A-71A.
10[10]Bristow MR,Anderson FL,Port JD,et al. Differences in β-adrenergre neu roeffector mechanisms in ischemic vs idiopathic dilated cardiomyopathv[ J ].Circulation, 1991. 84:1024-1039.
